Arcadia Biosciences Inc (17D.SG)
| Previous close | 1.8700 |
| Open | 1.8300 |
| Bid | 2.4200 x N/A |
| Ask | 2.5400 x N/A |
| Day's range | 1.8300 - 2.2200 |
| 52-week range | 1.7200 - 4.7600 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireArcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)
DALLAS, May 14, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today it has sold its non-GMO Resistant Starch (RS) Durum Wheat trait to longtime partner Corteva Agriscience. Under the terms of the agreement, Arcadia will receive $4 million and retain the right to continue using Resistant Starch Durum in its GoodWheat portfolio of wheat products, including pastas and mac & cheese. Corteva will acquire 24
Insider MonkeyArcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2024 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2024 Earnings Call Transcript May 9, 2024 Arcadia Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.78, expectations were $-2.52. RKDA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My […]
Simply Wall St.Arcadia Biosciences First Quarter 2024 Earnings: Beats Expectations
Arcadia Biosciences ( NASDAQ:RKDA ) First Quarter 2024 Results Key Financial Results Revenue: US$1.26m (down 17% from...
